The use of a defined number of tumor target cells and adoptively transferred tumor antigen‐specific patient‐derived CD8+ T cells makes it possible to monitor human anti‐tumor T‐cell responses in a controlled environment in the X‐mouse model. The gene discussed is CD8A; the disease is neoplasm.